Rights and permissions
About this article
Cite this article
Tolterodine less costly than oxybutynin in overactive bladder. Inpharma Wkly. 1363, 5 (2002). https://doi.org/10.2165/00128413-200213630-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200213630-00010